Abstract
Drug-induced liver injury (DILI) represents a spectrum of clinical presentations such as acute hepatocellular liver injury resulting in liver failure, cholestasis and jaundice, nodular regenerative hyperplasia, sinusoidal obstruction syndrome, or subclinical injury which is detected during routine testing. Furthermore, DILI can be divided into acute and chronic hepatotoxicity and also into direct dose-dependent toxicity versus idiosyncratic DILI. In all of these instances, the ultimate outcome of liver injury is often cell death. The cell death subroutine, however, depends largely on whether a toxic metabolite leads to the activation of the adaptive immune system resulting in hepatocyte killing via death receptor (DR) engagement, or if it is intrinsically toxic to hepatocytes. DR-mediated cell death is usually apoptotic while intrinsic toxicity can activate apoptosis or necrosis pathways. Autophagy is an alternative form of cell death which has been implicated in some drug toxicity models. However, for the most part activation of autophagy (and mitophagy in particular) seems to have a protective effect by removal of damaged organelles that would otherwise produce oxidative or proteolytic stress. In this chapter, we will explore the cell death subroutines, apoptosis, necrosis, necroptosis, and autophagy, as they pertain to drug-induced hepatotoxicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ALF :
-
Acute liver failure
- APAP :
-
Acetaminophen
- APAF1 :
-
Apoptotic peptidase-activating factor-1
- ASK1 :
-
Apoptosis signal-regulating kinase 1
- ASMase :
-
Acid sphingomyelinase
- ATF6 :
-
Activating transcription factor 6
- ATG :
-
Autophagy-related genes
- Cbl-b1 :
-
Casitas B lineage lymphoma-B1
- CCL4 :
-
Carbon tetrachloride
- CHOP :
-
CCAAT-enhancer-binding protein homologous protein
- cIAP :
-
Cellular inhibitor of apoptosis 1 and 2
- Cr :
-
Chromium
- CTLA4 :
-
Cytotoxic T-lymphocyte-associated protein 4
- DILI :
-
Drug-induced liver injury
- DR :
-
Death receptor
- ER Stress :
-
Endoplasmic reticulum stress
- ETC :
-
Electron transport chain
- FADD :
-
Fas-associated protein with death domain
- GRP78 :
-
Glucose regulatory peptide 78
- GSH :
-
Glutathione
- GSK3b :
-
Glycogen synthase kinase 3 beta
- GWAS :
-
Genome-wide association study
- INH :
-
Isonizaide
- JNK :
-
c-Jun N terminal kinase
- K18 :
-
Keratin 18
- KCC :
-
King’s college criteria
- KO :
-
Knockout
- HLA :
-
Human leukocyte antigen
- HMGB1 :
-
High-mobility group box 1
- IRE1α:
-
Inositol-requiring enzyme 1α
- IDILI :
-
Idiosyncratic drug-induced liver injury
- LPS :
-
Lipopolysaccharides
- LSEC :
-
Liver sinusoidal endothelial cells
- MAPK :
-
Mitogen-activated protein kinase
- MDSC :
-
Myeloid-derived suppressor cells
- MEF :
-
Mouse embryonic fibroblasts
- MELD :
-
Model for end-stage liver disease
- MHC :
-
Major histocompatibility complex
- miR :
-
Micro RNA
- MDB :
-
Mallory-Denk bodies
- MKK4 :
-
Mitogen-activated protein kinase kinase 4
- MLKL :
-
Mixed lineage kinase domain-like
- MOMP :
-
Mitochondrial outer membrane permeabilization
- MPT :
-
Mitochondrial permeability transition pore
- mTOR :
-
Mammalian target of rapamycin
- NAFLD :
-
Non-alcoholic fatty liver disease
- NASH :
-
Non-alcoholic steatohepatitis
- NFκB :
-
Nuclear factor κB
- NK :
-
Natural killer
- PD-1 :
-
Programmed cell death protein-1
- PERK :
-
Protein kinase RNA-like ER kinase
- PKC :
-
Protein kinase C
- POLG :
-
Polymerase γ
- PTPN6 :
-
Phospho-tyrosine phosphatase, non-receptor type 6
- RIPK1 :
-
Receptor interacting protein kinase 1
- RIPK3 :
-
Receptor interacting protein kinase 3
- ROS :
-
Reactive oxygen species
- Sab :
-
SH3BP5, SH3 domain-binding protein that preferentially associates with Bruton’s tyrosine kinase
- SMAC :
-
Second mitochondria-derived activator of caspases
- TAB2/3 :
-
TAK1-binding protein 2/3
- TAK1 :
-
Transforming growth factor-β-activated kinase 1
- TRAF2 :
-
TNF receptor-associated factor 2
- TRAIL :
-
TNF-related apoptosis-inducing ligand
- TNF :
-
Tumor necrosis factor
- TNFR :
-
Tumor necrosis factor receptor
- TRADD :
-
TNFR1-associated via death domain
- UPR :
-
Unfolded protein response
- VPA :
-
Valproic acid
- WT :
-
Wild type
- XIAP :
-
X-chromosome-linked inhibitor of apoptosis protein
References
Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW (2002) Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell 9(2):423–432. S1097276502004422 [pii]
Amir M, Zhao E, Fontana L, Rosenberg H, Tanaka K, Gao G, Czaja MJ (2013) Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation. Cell Death Differ 20(7):878–887. doi:10.1038/cdd.2013.21
An J, Mehrhof F, Harms C, Lattig-Tunnemann G, Lee SL, Endres M, Li M, Sellge G, Mandic AD, Trautwein C, Donath S (2013) ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosis. J Hepatol 58(2):297–305. doi:10.1016/j.jhep.2012.10.002
Antoine DJ, Williams DP, Kipar A, Jenkins RE, Regan SL, Sathish JG, Kitteringham NR, Park BK (2009) High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo. Toxicol Sci 112(2):521–531. doi:10.1093/toxsci/kfp235
Antoine DJ, Jenkins RE, Dear JW, Williams DP, McGill MR, Sharpe MR, Craig DG, Simpson KJ, Jaeschke H, Park BK (2012) Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 56(5):1070–1079. doi:10.1016/j.jhep.2011.12.019
Apostolova N, Gomez-Sucerquia LJ, Gortat A, Blas-Garcia A, Esplugues JV (2011) Autophagy as a rescue mechanism in efavirenz-induced mitochondrial dysfunction: a lesson from hepatic cells. Autophagy 7(11):1402–1404. doi:10.4161/auto.7.11.17653
Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104(2):155–162. doi:10.1172/JCI6926
Baulies A, Ribas V, Nunez S, Torres S, Alarcon-Vila C, Martinez L, Suda J, Ybanez MD, Kaplowitz N, Garcia-Ruiz C, Fernandez-Checa JC (2015) Lysosomal cholesterol accumulation sensitizes to acetaminophen hepatotoxicity by impairing mitophagy. Sci Rep 5:18017. doi:10.1038/srep18017
Bechmann LP, Jochum C, Kocabayoglu P, Sowa JP, Kassalik M, Gieseler RK, Saner F, Paul A, Trautwein C, Gerken G, Canbay A (2010) Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol 53(4):639–647. doi:10.1016/j.jhep.2010.04.029
Bissuel F, Bruneel F, Habersetzer F, Chassard D, Cotte L, Chevallier M, Bernuau J, Lucet JC, Trepo C (1994) Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J Intern Med 235(4):367–371
Bradham CA, Stachlewitz RF, Gao W, Qian T, Jayadev S, Jenkins G, Hannun Y, Lemasters JJ, Thurman RG, Brenner DA (1997) Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 25(5):1128–1135. doi:10.1002/hep.510250514. S027091399700222X [pii]
Campos G, Schmidt-Heck W, Ghallab A, Rochlitz K, Putter L, Medinas DB, Hetz C, Widera A, Cadenas C, Begher-Tibbe B, Reif R, Gunther G, Sachinidis A, Hengstler JG, Godoy P (2014) The transcription factor CHOP, a central component of the transcriptional regulatory network induced upon CCl4 intoxication in mouse liver, is not a critical mediator of hepatotoxicity. Arch Toxicol 88(6):1267–1280. doi:10.1007/s00204-014-1240-8
Caulin C, Salvesen GS, Oshima RG (1997) Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 138(6):1379–1394
Chakraborty M, Fullerton AM, Semple K, Chea LS, Proctor WR, Bourdi M, Kleiner DE, Zeng X, Ryan PM, Dagur PK, Berkson JD, Reilly TP, Pohl LR (2015) Drug-induced allergic hepatitis developed in mice when myeloid-derived suppressor cells were depleted prior to halothane treatment. Hepatology. doi:10.1002/hep.27764
Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410(6824):37–40. doi:10.1038/35065000. 35065000 [pii]
Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M (2006) The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124(3):601–613. doi:10.1016/j.cell.2006.01.021. S0092-8674(06)00113-9 [pii]
Chen X, Li W, Ren J, Huang D, He WT, Song Y, Yang C, Li W, Zheng X, Chen P, Han J (2014) Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 24(1):105–121. doi:10.1038/cr.2013.171
Chen R, Zhang Y, Tang S, Lv X, Wu S, Sun F, Xia Y, Zhan SY (2015) The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a case-control study. J Clin Pharm Ther 40(1):110–115. doi:10.1111/jcpt.12211
Corazza N, Jakob S, Schaer C, Frese S, Keogh A, Stroka D, Kassahn D, Torgler R, Mueller C, Schneider P, Brunner T (2006) TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J Clin Invest 116(9):2493–2499. doi:10.1172/JCI27726
Craig DG, Lee P, Pryde EA, Masterton GS, Hayes PC, Simpson KJ (2011) Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int 31(8):1127–1136. doi:10.1111/j.1478-3231.2011.02528.x
Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, Graham J, Park BK, Dillon JF, Bernal W, Cordell HJ, Pirmohamed M, Aithal GP, Day CP, DILIGEN Study, International SAEC (2009) HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 41(7):816–819. doi:10.1038/ng.379
Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, Eftychi C, Lin J, Corona T, Hermance N, Zelic M, Kirsch P, Basic M, Bleich A, Kelliher M, Pasparakis M (2014) RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513(7516):90–94. doi:10.1038/nature13608
Dara L, Ji C, Kaplowitz N (2011) The contribution of endoplasmic reticulum stress to liver diseases. Hepatology 53(5):1752–1763. doi:10.1002/hep.24279
Dara L, Han D, Kaplowitz N. (2012) Mechanisms of cell death and relevance to drug toxicity. Drug induced liver disease, 3rd ed. Academic Press is an imprint of ElsevierCambridge, Massachusetts
Dara L, Johnson H, Suda J, Win S, Gaarde W, Han D, Kaplowitz N (2015a) Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis. Hepatology 62(6):1847–1857. doi:10.1002/hep.27939
Dara L, Liu ZX, Kaplowitz N (2015b) Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications. Liver Int 36(2):158–165. doi:10.1111/liv.12988
Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1(2):112–119. doi:10.1038/nchembio711. nchembio711 [pii]
Degterev A, Zhou W, Maki JL, Yuan J (2014) Assays for necroptosis and activity of RIP kinases. Methods Enzymol 545:1–33. doi:10.1016/B978-0-12-801430-1.00001-9
Deutsch M, Graffeo CS, Rokosh R, Pansari M, Ochi A, Levie EM, Van Heerden E, Tippens DM, Greco S, Barilla R, Tomkotter L, Zambirinis CP, Avanzi N, Gulati R, Pachter HL, Torres-Hernandez A, Eisenthal A, Daley D, Miller G (2015) Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis 6:e1759. doi:10.1038/cddis.2015.126
Feng G, Kaplowitz N (2000) Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody. J Clin Invest 105(3):329–339. doi:10.1172/JCI7398
Fredriksson L, Herpers B, Benedetti G, Matadin Q, Puigvert JC, de Bont H, Dragovic S, Vermeulen NP, Commandeur JN, Danen E, de Graauw M, van de Water B (2011) Diclofenac inhibits tumor necrosis factor-alpha-induced nuclear factor-kappaB activation causing synergistic hepatocyte apoptosis. Hepatology 53(6):2027–2041. doi:10.1002/hep.24314
Fredriksson L, Wink S, Herpers B, Benedetti G, Hadi M, de Bont H, Groothuis G, Luijten M, Danen E, de Graauw M, Meerman J, van de Water B (2014) Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFalpha-mediated hepatotoxicity. Toxicol Sci 140(1):144–159. doi:10.1093/toxsci/kfu072
French LE, Tschopp J (1999) The TRAIL to selective tumor death. Nat Med 5(2):146–147. doi:10.1038/5505
Fromenty B, Pessayre D (1995) Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 67(1):101–154
Fu L, Lin YD, Elrod HA, Yue P, Oh Y, Li B, Tao H, Chen GZ, Shin DM, Khuri FR, Sun SY (2010) c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL. Mol Cancer 9:315. doi:10.1186/1476–4598–9-315
Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nunez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G (2012) Molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012. Cell Death Differ 19(1):107–120. doi:10.1038/cdd.2011.96
Geserick P, Wang J, Schilling R, Horn S, Harris PA, Bertin J, Gough PJ, Feoktistova M, Leverkus M (2015) Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death Dis 6:e1884. doi:10.1038/cddis.2015.240
Gores GJ, Kaufmann SH (2001) Is TRAIL hepatotoxic? Hepatology 34(1):3–6. doi:10.1053/jhep.2001.25173
Grove JI, Aithal GP (2015) Human leukocyte antigen genetic risk factors of drug-induced liver toxicology. Expert Opin Drug Metab Toxicol 11(3):395–409. doi:10.1517/17425255.2015.992414
Guicciardi ME, Gores GJ (2009) Life and death by death receptors. FASEB J 23(6):1625–1637. doi:10.1096/fj.08-111005
Gunawan BK, Liu ZX, Han D, Hanawa N, Gaarde WA, Kaplowitz N (2006) c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 131(1):165–178. doi:10.1053/j.gastro.2006.03.045. S0016-5085(06)00712-8 [pii]
Han D, Hanawa N, Saberi B, Kaplowitz N (2006) Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic Biol Med 41(4):627–639. doi:10.1016/j.freeradbiomed.2006.05.002. S0891-5849(06)00294-2 [pii]
Han D, Dara L, Win S, Than TA, Yuan L, Abbasi SQ, Liu ZX, Kaplowitz N (2013) Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. Trends Pharmacol Sci 34(4):243–253. doi:10.1016/j.tips.2013.01.009
Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D, Kaplowitz N (2008) Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 283(20):13565–13577. doi:10.1074/jbc.M708916200. M708916200 [pii]
Hatting M, Zhao G, Schumacher F, Sellge G, Al Masaoudi M, Gabetaler N, Boekschoten M, Muller M, Liedtke C, Cubero FJ, Trautwein C (2013) Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents. Hepatology 57(6):2189–2201. doi:10.1002/hep.26271
Hautekeete ML, Horsmans Y, Van Waeyenberge C, Demanet C, Henrion J, Verbist L, Brenard R, Sempoux C, Michielsen PP, Yap PS, Rahier J, Geubel AP (1999) HLA association of amoxicillin-clavulanate—induced hepatitis. Gastroenterology 117(5):1181–1186
Hetz C, Chevet E, Harding HP (2013) Targeting the unfolded protein response in disease. Nat Rev Drug Discov 12(9):703–719. doi:10.1038/nrd3976
Higuchi H, Grambihler A, Canbay A, Bronk SF, Gores GJ (2004) Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 279(1):51–60. doi:10.1074/jbc.M309476200
Hildebrand JM, Tanzer MC, Lucet IS, Young SN, Spall SK, Sharma P, Pierotti C, Garnier JM, Dobson RC, Webb AI, Tripaydonis A, Babon JJ, Mulcair MD, Scanlon MJ, Alexander WS, Wilks AF, Czabotar PE, Lessene G, Murphy JM, Silke J (2014) Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci U S A 111(42):15072–15077. doi:10.1073/pnas.1408987111
Hirata K, Takagi H, Yamamoto M, Matsumoto T, Nishiya T, Mori K, Shimizu S, Masumoto H, Okutani Y (2008) Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study. Pharmacogenomics J 8(1):29–33. doi:10.1038/sj.tpj.6500442
Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1(6):489–495. doi:10.1038/82732
Hu J, Han H, Lau MY, Lee H, MacVeigh-Aloni M, Ji C (2015) Effects of combined alcohol and anti-HIV drugs on cellular stress responses in primary hepatocytes and hepatic stellate and kupffer cells. Alcohol Clin Exp Res 39(1):11–20. doi:10.1111/acer.12608
Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388(6638):190–195. doi:10.1038/40657
Ji C, Mehrian-Shai R, Chan C, Hsu YH, Kaplowitz N (2005) Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcohol Clin Exp Res 29(8):1496–1503. 00000374-200508000-00017 [pii]
Jost PJ, Grabow S, Gray D, McKenzie MD, Nachbur U, Huang DC, Bouillet P, Thomas HE, Borner C, Silke J, Strasser A, Kaufmann T (2009) XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 460(7258):1035–1039. doi:10.1038/nature08229
Kahraman A, Barreyro FJ, Bronk SF, Werneburg NW, Mott JL, Akazawa Y, Masuoka HC, Howe CL, Gores GJ (2008) TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology 47(4):1317–1330. doi:10.1002/hep.22136
Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A, Waisman A, Brenner O, Haffner R, Gustafsson E, Ramakrishnan P, Lapidot T, Wallach D (2004) Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 173(5):2976–2984
Kang YJ, Bang BR, Han KH, Hong L, Shim EJ, Ma J, Lerner RA, Otsuka M (2015) Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling. Nat Commun 6:8371. doi:10.1038/ncomms9371
Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3(3):221–227. doi:10.1038/ni0302-221. ni0302-221 [pii]
Kasof GM, Prosser JC, Liu D, Lorenzi MV, Gomes BC (2000) The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria. FEBS Lett 473(3):285–291
Kassahun K, Farrell K, Abbott F (1991) Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans. Drug Metab Dispos 19(2):525–535
Kassahun K, Hu P, Grillo MP, Davis MR, Jin L, Baillie TA (1994) Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes. Chem Biol Interact 90(3):253–275
Kaufmann T, Jost PJ, Pellegrini M, Puthalakath H, Gugasyan R, Gerondakis S, Cretney E, Smyth MJ, Silke J, Hakem R, Bouillet P, Mak TW, Dixit VM, Strasser A (2009) Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity 30(1):56–66. doi:10.1016/j.immuni.2008.10.017. S1074-7613(08)00543-8 [pii]
Kew MC (2000) Serum aminotransferase concentration as evidence of hepatocellular damage. Lancet 355(9204):591–592. doi:10.1016/S0140-6736(99)00219-6
Kim HE, Du F, Fang M, Wang X (2005) Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci U S A 102(49):17545–17550. doi:10.1073/pnas.0507900102. 0507900102 [pii]
Kindmark A, Jawaid A, Harbron CG, Barratt BJ, Bengtsson OF, Andersson TB, Carlsson S, Cederbrant KE, Gibson NJ, Armstrong M, Lagerstrom-Fermer ME, Dellsen A, Brown EM, Thornton M, Dukes C, Jenkins SC, Firth MA, Harrod GO, Pinel TH, Billing-Clason SM, Cardon LR, March RE (2008) Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J 8(3):186–195. doi:10.1038/sj.tpj.6500458
Klionsky DJ, Cregg JM, Dunn WA Jr, Emr SD, Sakai Y, Sandoval IV, Sibirny A, Subramani S, Thumm M, Veenhuis M, Ohsumi Y (2003) A unified nomenclature for yeast autophagy-related genes. Dev Cell 5(4):539–545
Knolle PA, Thimme R (2014) Hepatic immune regulation and its involvement in viral hepatitis infection. Gastroenterology 146(5):1193–1207. doi:10.1053/j.gastro.2013.12.036
Kon K, Kim JS, Jaeschke H, Lemasters JJ (2004) Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 40(5):1170–1179. doi:10.1002/hep.20437
Ku NO, Strnad P, Bantel H, Bishr Omary M (2016) Keratins: biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology. doi:10.1002/hep.28493
Kurosaki M, Takagi H, Mori M (2000) HLA-A33/B44/DR6 is highly related to intrahepatic cholestasis induced by tiopronin. Dig Dis Sci 45(6):1103–1108
Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12(9):735–739
Lavallard VJ, Bonnafous S, Patouraux S, Saint-Paul MC, Rousseau D, Anty R, Le Marchand-Brustel Y, Tran A, Gual P (2011) Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease. PLoS One 6(3):e17599. doi:10.1371/journal.pone.0017599
Lee KH, Feig C, Tchikov V, Schickel R, Hallas C, Schutze S, Peter ME, Chan AC (2006) The role of receptor internalization in CD95 signaling. EMBO J 25(5):1009–1023. doi:10.1038/sj.emboj.7601016
Lei K, Davis RJ (2003) JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A 100(5):2432–2437. doi:10.1073/pnas.0438011100. 0438011100 [pii]
Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB, Bar-Sagi D, Davis RJ (2002) The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 22(13):4929–4942
Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A (1994) Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 153(4):1778–1788
Leist M, Gantner F, Naumann H, Bluethmann H, Vogt K, Brigelius-Flohe R, Nicotera P, Volk HD, Wendel A (1997) Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology 112(3):923–934. S0016508597001327 [pii]
Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366(1–2):177–196
Levy RH, Rettenmeier AW, Anderson GD, Wilensky AJ, Friel PN, Baillie TA, Acheampong A, Tor J, Guyot M, Loiseau P (1990) Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid. Clin Pharmacol Ther 48(3):225–235
Lewis JH, Ranard RC, Caruso A, Jackson LK, Mullick F, Ishak KG, Seeff LB, Zimmerman HJ (1989) Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 9(5):679–685
Liedtke C, Bangen JM, Freimuth J, Beraza N, Lambertz D, Cubero FJ, Hatting M, Karlmark KR, Streetz KL, Krombach GA, Tacke F, Gassler N, Riethmacher D, Trautwein C (2011) Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 141(6):2176–2187. doi:10.1053/j.gastro.2011.08.037. S0016-5085(11)01220-0 [pii]
Linkermann A, Green DR (2014) Necroptosis. N Engl J Med 370(5):455–465. doi:10.1056/NEJMra1310050
Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86(1):147–157. S0092-8674(00)80085-9 [pii]
Liu H, Lo CR, Czaja MJ (2002) NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 35(4):772–778. doi:10.1053/jhep.2002.32534. S0270913902315994 [pii]
Lockshin RA, Williams CM (1965) Programmed cell death‑I. Cytology of degeneration in the intersegmental muscles of the pernyi silkmoth. J Insect Physiol 11:123–133
Lockshin RA, Zakeri Z (2004) Apoptosis, autophagy, and more. Int J Biochem Cell Biol 36(12):2405–2419. doi:10.1016/j.biocel.2004.04.011. S1357272504001669 [pii]
LoGuidice A, Boelsterli UA (2011) Acetaminophen overdose-induced liver injury in mice is mediated by peroxynitrite independently of the cyclophilin D-regulated permeability transition. Hepatology 54(3):969–978. doi:10.1002/hep.24464
Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5(4):331–342. doi:10.1038/nri1594
Lou H, Kaplowitz N (2007) Glutathione depletion down-regulates tumor necrosis factor alpha-induced NF-kappaB activity via IkappaB kinase-dependent and -independent mechanisms. J Biol Chem 282(40):29470–29481. doi:10.1074/jbc.M706145200
Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, Day CP, Ruiz-Cabello F, Donaldson PT, Stephens C, Pirmohamed M, Romero-Gomez M, Navarro JM, Fontana RJ, Miller M, Groome M, Bondon-Guitton E, Conforti A, Stricker BH, Carvajal A, Ibanez L, Yue QY, Eichelbaum M, Floratos A, Pe'er I, Daly MJ, Goldstein DB, Dillon JF, Nelson MR, Watkins PB, Daly AK, Spanish DR, Eudragene, Dilin, Diligen, International SAEC (2011) Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 141(1):338–347. doi:10.1053/j.gastro.2011.04.001
Luedde T, Kaplowitz N, Schwabe RF (2014) Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147(4):765–783. doi:10.1053/j.gastro.2014.07.018e764
Lundback P, Lea JD, Sowinska A, Ottosson L, Melin Furst C, Steen J, Aulin C, Clarke JI, Kipar A, Klevenvall L, Yang H, Palmblad K, Park BK, Tracey KJ, Blom AM, Andersson U, Antoine DJ, Erlandsson Harris H (2016) A novel HMGB1 neutralizing chimeric antibody attenuates DILI and post-injury inflammation. Hepatology. doi:10.1002/hep.28736
Mak A, Uetrecht J (2015) The role of CD8 T cells in amodiaquine-induced liver injury in PD1−/− mice cotreated with anti-CTLA-4. Chem Res Toxicol. doi:10.1021/acs.chemrestox.5b00137
Malhi H (2007) TRAILs and tribulation. Hepatology 46(5):1320–1322. doi:10.1002/hep.21913
Malhi H, Guicciardi ME, Gores GJ (2010) Hepatocyte death: a clear and present danger. Physiol Rev 90(3):1165–1194. doi:10.1152/physrev.00061.2009. 90/3/1165 [pii]
Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jagel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A, Team P-S (2008) HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358(6):568–579. doi:10.1056/NEJMoa0706135
McGill MR, Du K, Xie Y, Bajt ML, Ding WX, Jaeschke H (2015) The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injury. Xenobiotica 45(5):442–449. doi:10.3109/00498254.2014.986250
McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C et al (1995) Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 333(17):1099–1105. doi:10.1056/NEJM199510263331702
Metushi IG, Hayes MA, Uetrecht J (2015) Treatment of PD-1(−/−) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients. Hepatology 61(4):1332–1342. doi:10.1002/hep.27549
Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114(2):181–190. S009286740300521X [pii]
Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451(7182):1069–1075. doi:10.1038/nature06639. nature06639 [pii]
Monshi MM, Faulkner L, Gibson A, Jenkins RE, Farrell J, Earnshaw CJ, Alfirevic A, Cederbrant K, Daly AK, French N, Pirmohamed M, Park BK, Naisbitt DJ (2013) Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury. Hepatology 57(2):727–739. doi:10.1002/hep.26077
Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S, Lewis R, Lalaoui N, Metcalf D, Webb AI, Young SN, Varghese LN, Tannahill GM, Hatchell EC, Majewski IJ, Okamoto T, Dobson RC, Hilton DJ, Babon JJ, Nicola NA, Strasser A, Silke J, Alexander WS (2013) The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39(3):443–453. doi:10.1016/j.immuni.2013.06.018
Musso G, Gambino R, Cassader M, Pagano G (2011) Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43(8):617–649. doi:10.3109/07853890.2010.518623
Nagai H, Matsumaru K, Feng G, Kaplowitz N (2002) Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes. Hepatology 36(1):55–64. doi:10.1053/jhep.2002.33995. S027091390200006X [pii]
Naviaux RK, Nguyen KV (2004) POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 55(5):706–712. doi:10.1002/ana.20079
Ni HM, Bockus A, Boggess N, Jaeschke H, Ding WX (2012a) Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology 55(1):222–232. doi:10.1002/hep.24690
Ni HM, Boggess N, McGill MR, Lebofsky M, Borude P, Apte U, Jaeschke H, Ding WX (2012b) Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicol Sci 127(2):438–450. doi:10.1093/toxsci/kfs133
Ni HM, McGill MR, Chao X, Du K, Williams JA, Xie Y, Jaeschke H, Ding WX (2016) Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice. J Hepatol 65(2):354–362. doi:10.1016/j.jhep.2016.04.025
Nicoletti P, Werk AN, Sawle A, Shen Y, Urban TJ, Coulthard SA, Bjornsson ES, Cascorbi I, Floratos A, Stammschulte T, Gundert-Remy U, Nelson MR, Aithal GP, Daly AK, International Drug-induced Liver Injury C (2016) HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury. Pharmacogenet Genomics 26(5):218–224. doi:10.1097/FPC.0000000000000209
O'Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSween RN, Mills PR (2000) Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 47(5):717–720
Omary MB, Ku NO, Strnad P, Hanada S (2009) Toward unraveling the complexity of simple epithelial keratins in human disease. J Clin Invest 119(7):1794–1805. doi:10.1172/JCI37762
Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci U S A 109(25):9959–9964. doi:10.1073/pnas.1207934109
Phillips E, Bartlett JA, Sanne I, Lederman MM, Hinkle J, Rousseau F, Dunn D, Pavlos R, James I, Mallal SA, Haas DW (2013) Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa. J Acquir Immune Defic Syndr 62(2):e55–e57. doi:10.1097/QAI.0b013e31827ca50f
Pichler WJ (2002) Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2(4):301–305
Pierce RH, Campbell JS, Stephenson AB, Franklin CC, Chaisson M, Poot M, Kavanagh TJ, Rabinovitch PS, Fausto N (2000) Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line. Am J Pathol 157(1):221–236. doi:10.1016/S0002-9440(10)64533-6. S0002-9440(10)64533-6 [pii]
Ponchaut S, van Hoof F, Veitch K (1992) In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions. Biochem Pharmacol 43(11):2435–2442
Porceddu M, Buron N, Roussel C, Labbe G, Fromenty B, Borgne-Sanchez A (2012) Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria. Toxicol Sci 129(2):332–345. doi:10.1093/toxsci/kfs197
Protzer U, Maini MK, Knolle PA (2012) Living in the liver: hepatic infections. Nat Rev Immunol 12(3):201–213. doi:10.1038/nri3169
Quarato G, Guy CS, Grace CR, Llambi F, Nourse A, Rodriguez DA, Wakefield R, Frase S, Moldoveanu T, Green DR (2016) Sequential engagement of distinct MLKL phosphatidylinositol-binding sites executes necroptosis. Mol Cell 61(4):589–601. doi:10.1016/j.molcel.2016.01.011
Rahman SM, Schroeder-Gloeckler JM, Janssen RC, Jiang H, Qadri I, Maclean KN, Friedman JE (2007) CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis. Hepatology 45(5):1108–1117. doi:10.1002/hep.21614
Ramachandran A, Lebofsky M, Baines CP, Lemasters JJ, Jaeschke H (2011) Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury. Free Radic Res 45(2):156–164. doi:10.3109/10715762.2010.520319
Ramachandran A, McGill MR, Xie Y, Ni HM, Ding WX, Jaeschke H (2013) The receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 58(6):2099–2108. doi:10.1002/hep.26547
Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8(7):519–529. doi:10.1038/nrm2199
Rutherford A, King LY, Hynan LS, Vedvyas C, Lin W, Lee WM, Chung RT, Group ALFS (2012) Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology 143(5):1237–1243. doi:10.1053/j.gastro.2012.07.113
Sabapathy K, Hochedlinger K, Nam SY, Bauer A, Karin M, Wagner EF (2004) Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell 15(5):713–725. doi:10.1016/j.molcel.2004.08.028. S1097276504005143 [pii]
Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME (1999) Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274(32):22532–22538
Sharma SK, Balamurugan A, Saha PK, Pandey RM, Mehra NK (2002) Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med 166(7):916–919. doi:10.1164/rccm.2108091
Silva MF, Ruiter JP, Illst L, Jakobs C, Duran M, de Almeida IT, Wanders RJ (1997) Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation in vitro. J Inherit Metab Dis 20(3):397–400
Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, Wright TM, Meyer J, Paulding CA (2010) A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet 42(8):711–714. doi:10.1038/ng.632
Siu WP, Pun PB, Latchoumycandane C, Boelsterli UA (2008) Bax-mediated mitochondrial outer membrane permeabilization (MOMP), distinct from the mitochondrial permeability transition, is a key mechanism in diclofenac-induced hepatocyte injury: multiple protective roles of cyclosporin A. Toxicol Appl Pharmacol 227(3):451–461. doi:10.1016/j.taap.2007.11.030. S0041-008X(07)00523-6 [pii]
Song L, Zhang Z, Zhang J, Zhu X, He L, Shi Z, Gao L, Feng F (2016) Ratio of microRNA-122/155 in isoniazid-induced acute liver injury in mice. Exp Ther Med 12(2):889–894. doi:10.3892/etm.2016.3375
Spraggs CF, Budde LR, Briley LP, Bing N, Cox CJ, King KS, Whittaker JC, Mooser VE, Preston AJ, Stein SH, Cardon LR (2011) HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. Journal of Clin Oncol 29(6):667–673. doi:10.1200/JCO.2010.31.3197
Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, French NS, Dhaun N, Webb DJ, Costello EM, Neoptolemos JP, Moggs J, Goldring CE, Park BK (2011) Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 54(5):1767–1776. doi:10.1002/hep.24538
Stewart JD, Horvath R, Baruffini E, Ferrero I, Bulst S, Watkins PB, Fontana RJ, Day CP, Chinnery PF (2010) Polymerase gamma gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology 52(5):1791–1796. doi:10.1002/hep.23891
Stine JG, Chalasani N (2015) Chronic liver injury induced by drugs: a systematic review. Liver Int 35(11):2343–2353. doi:10.1111/liv.12958
Strasser A, Jost PJ, Nagata S (2009) The many roles of FAS receptor signaling in the immune system. Immunity 30(2):180–192. doi:10.1016/j.immuni.2009.01.001
Strnad P, Paschke S, Jang KH, Ku NO (2012) Keratins: markers and modulators of liver disease. Curr Opin Gastroenterol 28(3):209–216. doi:10.1097/MOG.0b013e3283525cb8
Suda, J., Dara, L., Yang, L., Aghajan, M., Song, Y., Kaplowitz, N. & Liu, Z. X. 2016. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-kappaB. J Immunol, 197, 3120–3129
Sun X, Lee J, Navas T, Baldwin DT, Stewart TA, Dixit VM (1999) RIP3, a novel apoptosis-inducing kinase. J Biol Chem 274(24):16871–16875
Takahashi N, Vereecke L, Bertrand MJ, Duprez L, Berger SB, Divert T, Goncalves A, Sze M, Gilbert B, Kourula S, Goossens V, Lefebvre S, Gunther C, Becker C, Bertin J, Gough PJ, Declercq W, van Loo G, Vandenabeele P (2014) RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513(7516):95–99. doi:10.1038/nature13706
Takeda K, Kojima Y, Ikejima K, Harada K, Yamashina S, Okumura K, Aoyama T, Frese S, Ikeda H, Haynes NM, Cretney E, Yagita H, Sueyoshi N, Sato N, Nakanuma Y, Smyth MJ, Okumura K (2008) Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci U S A 105(31):10895–10900. doi:10.1073/pnas.0802702105
Takemoto K, Hatano E, Iwaisako K, Takeiri M, Noma N, Ohmae S, Toriguchi K, Tanabe K, Tanaka H, Seo S, Taura K, Machida K, Takeda N, Saji S, Uemoto S, Asagiri M (2014) Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure. FEBS Open Bio 4:777–787. doi:10.1016/j.fob.2014.08.007
Thakral S, Ghoshal K (2015) miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir. Curr Gene Ther 15(2):142–150
Thapaliya S, Wree A, Povero D, Inzaugarat ME, Berk M, Dixon L, Papouchado BG, Feldstein AE (2014) Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model. Dig Dis Sci 59(6):1197–1206. doi:10.1007/s10620-014-3167-6
Tian Z, Chen Y, Gao B (2013) Natural killer cells in liver disease. Hepatology 57(4):1654–1662. doi:10.1002/hep.26115
Tinel M, Berson A, Vadrot N, Descatoire V, Grodet A, Feldmann G, Thenot JP, Pessayre D (2004) Subliminal Fas stimulation increases the hepatotoxicity of acetaminophen and bromobenzene in mice. Hepatology 39(3):655–666. doi:10.1002/hep.20094
Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288(5467):870–874. doi:8440 [pii]
Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287(5453):664–666
Urban TJ, Daly AK, Aithal GP (2014) Genetic basis of drug-induced liver injury: present and future. Semin Liver Dis 34(2):123–133. doi:10.1055/s-0034-1375954
Uzi D, Barda L, Scaiewicz V, Mills M, Mueller T, Gonzalez-Rodriguez A, Valverde AM, Iwawaki T, Nahmias Y, Xavier R, Chung RT, Tirosh B, Shibolet O (2013) CHOP is a critical regulator of acetaminophen-induced hepatotoxicity. J Hepatol 59(3):495–503. doi:10.1016/j.jhep.2013.04.024
Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187(9):1477–1485
Volkmann X, Fischer U, Bahr MJ, Ott M, Lehner F, Macfarlane M, Cohen GM, Manns MP, Schulze-Osthoff K, Bantel H (2007) Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver. Hepatology 46(5):1498–1508. doi:10.1002/hep.21846
Volkmann X, Anstaett M, Hadem J, Stiefel P, Bahr MJ, Lehner F, Manns MP, Schulze-Osthoff K, Bantel H (2008) Caspase activation is associated with spontaneous recovery from acute liver failure. Hepatology 47(5):1624–1633. doi:10.1002/hep.22237
Voskoboinik I, Whisstock JC, Trapani JA (2015) Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol 15(6):388–400. doi:10.1038/nri3839
Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5(2):157–163. doi:10.1038/5517
Wang S, Kaufman RJ (2012) The impact of the unfolded protein response on human disease. J Cell Biol 197(7):857–867. doi:10.1083/jcb.201110131
Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106(11):4402–4407. doi:10.1073/pnas.0813371106
Watkins PB (2009) Biomarkers for the diagnosis and management of drug-induced liver injury. Semin Liver Dis 29(4):393–399. doi:10.1055/s-0029-1240008
Wei CY, Chung WH, Huang HW, Chen YT, Hung SI (2012) Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol 129(6):1562–1569 . doi:10.1016/j.jaci.2011.12.990e1565
Williams CD, McGill MR, Farhood A, Jaeschke H (2013) Fas receptor-deficient lpr mice are protected against acetaminophen hepatotoxicity due to higher glutathione synthesis and enhanced detoxification of oxidant stress. Food Chem Toxicol 58:228–235. doi:10.1016/j.fct.2013.04.031
Wiltshire C, Matsushita M, Tsukada S, Gillespie DA, May GH (2002) A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. Biochem J 367(Pt 3):577–585. doi:10.1042/BJ20020553
Wiltshire C, Gillespie DA, May GH (2004) Sab (SH3BP5), a novel mitochondria-localized JNK-interacting protein. Biochem Soc Trans 32(Pt 6):1075–1077. doi:10.1042/BST0321075
Win S, Than TA, Han D, Petrovic LM, Kaplowitz N (2011) c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J Biol Chem 286(40):35071–35078. doi:10.1074/jbc.M111.276089. M111.276089 [pii]
Win S, Than TA, Fernandez-Checa JC, Kaplowitz N (2014) JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death. Cell Death Dis 5:e989. doi:10.1038/cddis.2013.522
Win S, Than TA, Le BH, Garcia-Ruiz C, Fernandez-Checa JC, Kaplowitz N (2015) Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity. J Hepatol 62(6):1367–1374. doi:10.1016/j.jhep.2015.01.032
Win S, Than TA, Min RW, Aghajan M, Kaplowitz N (2016) c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src. Hepatology 63(6):1987–2003. doi:10.1002/hep.28486
Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM (2009) Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Hepatology 50(5):1421–1430. doi:10.1002/hep.23167
Woolbright BL, Jaeschke H (2015) Sterile inflammation in acute liver injury: myth or mystery? Expert Rev Gastroenterol Hepatol 9(8):1027–1029. doi:10.1586/17474124.2015.1060855
Wuillemin N, Adam J, Fontana S, Krahenbuhl S, Pichler WJ, Yerly D (2013) HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin. J Immunol 190(10):4956–4964. doi:10.4049/jimmunol.1202949
Xie Z, Klionsky DJ (2007) Autophagosome formation: core machinery and adaptations. Nat Cell Biol 9(10):1102–1109. doi:10.1038/ncb1007-1102
Xie Y, Xiao F, Luo L, Zhong C (2014) Activation of autophagy protects against ROS-mediated mitochondria-dependent apoptosis in L-02 hepatocytes induced by Cr(VI). Cell Physiol Biochem 33(3):705–716. doi:10.1159/000358646
Xu CF, Johnson T, Wang X, Carpenter C, Graves A, Warren L, Xue Z, King KS, Fraser DJ, Stinnett S, Briley LP, Mitrica I, Spraggs CF, Nelson MR, Tada H, du Bois A, Powles T, Kaplowitz N, Pandite LN (2015) HLA-B*57:01 confers susceptibility to pazopanib-associated liver injury in patients with cancer. Clin Cancer Res 22(6):1371–1377. doi:10.1158/1078-0432.CCR-15-2044
Yin XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA, Korsmeyer SJ (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400(6747):886–891. doi:10.1038/23730
Yuan L, Kaplowitz N (2013) Mechanisms of drug-induced liver injury. Clin Liver Dis 17(4):507–518 . doi:10.1016/j.cld.2013.07.002vii
Zhang YF, He W, Zhang C, Liu XJ, Lu Y, Wang H, Zhang ZH, Chen X, Xu DX (2014) Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice. Toxicol Lett 225(3):445–453. doi:10.1016/j.toxlet.2014.01.005
Zhang L, Dittmer MR, Blackwell K, Workman LM, Hostager B, Habelhah H (2015) TRAIL activates JNK and NF-kappaB through RIP1-dependent and -independent pathways. Cell Signal 27(2):306–314. doi:10.1016/j.cellsig.2014.11.014
Zhang J, Doshi U, Suzuki A, Chang CW, Borlak J, Li AP, Tong W (2016) Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: results from 152 marketed drugs with known liver injury profiles. Chem Biol Interact 255:3–11. doi:10.1016/j.cbi.2015.11.008
Zou H, Henzel WJ, Liu X, Lutschg A, Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90(3):405–413. S0092-8674(00)80501-2 [pii]
Zou W, Liu X, Yue P, Zhou Z, Sporn MB, Lotan R, Khuri FR, Sun SY (2004) c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Cancer Res 64(20):7570–7578. doi:10.1158/0008-5472.CAN-04-1238
Zou W, Yue P, Khuri FR, Sun SY (2008) Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation. Cancer Res 68(18):7484–7492. doi:10.1158/0008-5472.CAN-08-1318
Acknowledgment
This work was supported by NIH grants K08DK109141(LD), R01DK067215 (NK), P30DK048522 (NK).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Dara, L., Kaplowitz, N. (2017). Cell Death in Drug-Induced Liver Injury. In: Ding, WX., Yin, XM. (eds) Cellular Injury in Liver Diseases. Cell Death in Biology and Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-53774-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-53774-0_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-53773-3
Online ISBN: 978-3-319-53774-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)